Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Debt to Equity (2020 - 2021)

Historic Debt to Equity for Burning Rock Biotech (BNR) over the last 2 years, with Q4 2021 value amounting to $0.0.

  • Burning Rock Biotech's Debt to Equity fell 9103.52% to $0.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $0.0, marking a year-over-year decrease of 9103.52%. This contributed to the annual value of $0.0 for FY2021, which is 9103.52% down from last year.
  • Burning Rock Biotech's Debt to Equity amounted to $0.0 in Q4 2021, which was down 9103.52% from $0.01 recorded in Q4 2020.
  • Over the past 5 years, Burning Rock Biotech's Debt to Equity peaked at $0.02 during Q2 2020, and registered a low of $0.0 during Q4 2021.